These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 25388738)

  • 21. Multiple sclerosis: a practical overview for clinicians.
    Rejdak K; Jackson S; Giovannoni G
    Br Med Bull; 2010; 95():79-104. PubMed ID: 20603280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a MS specialist nurse programme.
    Forbes A; While A; Mathes L; Griffiths P
    Int J Nurs Stud; 2006 Nov; 43(8):985-1000. PubMed ID: 16412443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Self-management education in multiple sclerosis services.
    Embrey N
    Nurs Times; 2005 Aug 23-29; 101(34):34-6. PubMed ID: 16149703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple sclerosis: a primary care perspective.
    Saguil A; Kane S; Farnell E
    Am Fam Physician; 2014 Nov; 90(9):644-52. PubMed ID: 25368924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis update.
    Markowitz CE
    Am J Manag Care; 2013 Nov; 19(16 Suppl):s294-300. PubMed ID: 24494618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel therapeutics in multiple sclerosis management: clinical applications.
    Leist T; Hunter SF; Kantor D; Markowitz C
    Am J Med; 2014 Jan; 127(1):S2. PubMed ID: 24384114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demographic, socioeconomic and clinical correlates of self-management in multiple sclerosis.
    Wilski M; Tasiemski T; Kocur P
    Disabil Rehabil; 2015; 37(21):1970-5. PubMed ID: 25510170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple sclerosis in childhood and adolescence.
    Tenembaum S
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S53-7. PubMed ID: 22206768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple Sclerosis Re-Examined: Essential and Emerging Clinical Concepts.
    Zurawski J; Stankiewicz J
    Am J Med; 2018 May; 131(5):464-472. PubMed ID: 29274753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The lived experience of relapsing multiple sclerosis: a phenomenological study.
    Miller CM
    J Neurosci Nurs; 1997 Oct; 29(5):294-304. PubMed ID: 9361999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nursing at a specialist diagnostic clinic for multiple sclerosis.
    Porter B; Keenan E
    Br J Nurs; 2003 Jun 12-25; 12(11):650, 652-6. PubMed ID: 12829964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropathic Pain Management: A Reference for the Clinical Nurse.
    Blumstein B; Barkley TW
    Medsurg Nurs; 2015; 24(6):381-9, 438. PubMed ID: 26863700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy of multiple sclerosis--current practice and future directions.
    Tullman MJ; Lublin FD; Miller AE
    J Rehabil Res Dev; 2002; 39(2):273-85. PubMed ID: 12051470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The challenge of managing patients with multiple sclerosis.
    MacLean R
    Nurs Times; 2004 Jan 27-Feb 2; 100(4):42-4. PubMed ID: 14974264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis.
    Sørensen PS
    J Neurol Sci; 2011 Dec; 311 Suppl 1():S29-34. PubMed ID: 22206763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis.
    He A; Spelman T; Jokubaitis V; Havrdova E; Horakova D; Trojano M; Lugaresi A; Izquierdo G; Grammond P; Duquette P; Girard M; Pucci E; Iuliano G; Alroughani R; Oreja-Guevara C; Fernandez-Bolaños R; Grand'Maison F; Sola P; Spitaleri D; Granella F; Terzi M; Lechner-Scott J; Van Pesch V; Hupperts R; Sánchez-Menoyo JL; Hodgkinson S; Rozsa C; Verheul F; Butzkueven H; Kalincik T;
    JAMA Neurol; 2015 Apr; 72(4):405-13. PubMed ID: 25665031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disability as an outcome in MS clinical trials.
    Ebers GC; Heigenhauser L; Daumer M; Lederer C; Noseworthy JH
    Neurology; 2008 Aug; 71(9):624-31. PubMed ID: 18480462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new era in the treatment of multiple sclerosis.
    Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies JM; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E
    Med J Aust; 2015 Aug; 203(3):139-41, 141e.1. PubMed ID: 26224184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Best Practices in Alemtuzumab Administration: Practical Recommendations for Infusion in Patients With Multiple Sclerosis.
    McEwan L; Caon C; Chieffe C; Mayer L; Saldana-King T; Miller CE
    J Infus Nurs; 2016; 39(2):93-104. PubMed ID: 26295502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.